CRSP
CRISPR Therapeutics AG
Price:
51.67
USD
Volume:
3,361,534
Switzerland | Biotechnology
CRSP Net Margin
As of 2025-07-03, the Net Margin of CRISPR Therapeutics AG (CRSP) is -981.5%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
CRSP Net Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | -981.5% |
| 2023-12-31 | -41.4% |
| 2022-12-31 | -54183.3% |
| 2021-12-31 | 41.3% |
| 2020-12-31 | -49842.9% |
| 2019-12-31 | 23.1% |
| 2018-12-31 | -5322.6% |
| 2017-12-31 | -166.8% |
| 2016-12-31 | -446.2% |
| 2015-12-31 | -12750% |
CRSP Net Margin - Peers Comparison